Revolutionising DNA

ADVANCING MEDICINES TO IMPROVE THE TREATMENT OF DISEASE

Touchlight appoints Dr. Michael Linden as Chief Scientific Officer

Touchlight is awarded runner-up in Spectator Economic Disruptor Award for the London / the South category

Touchlight announces collaboration with Janssen Biotech through Johnson and Johnson Innovation Centre

Touchlight is developing a wide range of dbDNA™ based products, internally and with world leading partners

Touchlight is collaborating with leading companies and institutions to develop dbDNA™ products